A detailed history of Oberweis Asset Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Oberweis Asset Management Inc holds 718,700 shares of NEO stock, worth $12.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
718,700
Previous 668,700 7.48%
Holding current value
$12.3 Million
Previous $9.27 Million 14.3%
% of portfolio
0.57%
Previous 0.59%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $670,000 - $886,500
50,000 Added 7.48%
718,700 $10.6 Million
Q2 2024

Aug 14, 2024

SELL
$13.01 - $15.77 $891,185 - $1.08 Million
-68,500 Reduced 9.29%
668,700 $9.27 Million
Q1 2024

May 15, 2024

BUY
$14.06 - $16.79 $4.84 Million - $5.78 Million
344,500 Added 87.73%
737,200 $11.6 Million
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $1.16 Million - $2.06 Million
99,300 Added 33.84%
392,700 $6.35 Million
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $976,860 - $1.44 Million
80,400 Added 37.75%
293,400 $3.61 Million
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $3 Million - $4.22 Million
213,000 New
213,000 $3.42 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $330,776 - $453,952
-17,300 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$19.57 - $24.1 $455,981 - $561,530
-23,300 Reduced 57.39%
17,300 $380,000
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $292,574 - $493,086
-24,100 Reduced 37.25%
40,600 $831,000
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $727,228 - $1.2 Million
64,700 New
64,700 $816,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.